For years the Knicks struggled with their overall team health as the front office made it a habit of over-investing in injury prone players. The illustrious list includes everyone from Jerome James to Amar’e Stoudemire as the franchise has lost more salary dollars to injury than any other team in the NBA over the past 11 seasons.
However things changed last year as Phil Jackson signed low-risk players like Robin Lopez , Kyle O’Quinn, and Derrick Williams. Rookie Kristaps Porzingis burst onto the scene playing 72 games, a total matched by All-Star forward Carmelo Anthony. As a result the team and its medical staff experienced a remarkable turnaround, finishing below the league average for the first time since the 2010-11 season.
Despite the success, Roger Hinds and his staff find themselves in a familiar spot as the Knicks returned to their previous ways, overspending on players with a poor track record of health. Derrick Rose and Joakim Noah were added via trade and free agency despite missing a combined 189 games to injury over the past three seasons. Last season proved Hinds and company are more than capable of keeping the Knicks players on the court but it remains to be seen if they can repeat this successes with another inherently risky roster.